載入...
P6
Tamoxifen, a selective estrogen receptor modulator, remains a standard of endocrine therapy for estrogen receptor alpha (ERα) positive breast cancer (Goldhirsch et al., 2013). Despite well-known advantages of tamoxifen treatment, approximately one third of patients experience a relapse or disease pr...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2015-11-01
|
| 叢編: | EJC Supplements |
| 在線閱讀: | http://www.sciencedirect.com/science/article/pii/S1359634915000051 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|